MBHFR Lab – Research – MHIR
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data | Technology Networks
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Emerging Therapeutic Targets for Heart Failure | Current Cardiology Reports
Precision medicine for heart failure based on molecular mechanisms: The 2019 ISHR Research Achievement Award Lecture - ScienceDirect
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction? | The Egyptian Heart Journal | Full Text
Characterization of Screen Failures Among Patients Evaluated for Transcatheter Tricuspid Valve Repair (TriSelect-Study) | JACC: Cardiovascular Interventions
APP Webinar (Full Length): BAT - A Novel Approach to Class II/III Heart Failure Management - YouTube
Sensors | Free Full-Text | Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Frontiers | Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair | Signal Transduction and Targeted Therapy
The role of the genome regulatory network in heart failure | Nature Cardiovascular Research
Cancers | Free Full-Text | Harnessing RKIP to Combat Heart Disease and Cancer
Heart Failure - A practical approach presented by the CardioNerds
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction | Circulation: Arrhythmia and Electrophysiology
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Novel Devices in Heart Failure: BAT, Atrial Shunts, and Phrenic Nerve Stimulation | JACC: Heart Failure
Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions | Journal of the American Heart Association
Frontiers | Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Ultromics joins FNIH partnership to transform heart failure detection - Ultromics
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine
